Literature DB >> 17028488

Drug interactions and drugs that affect blood pressure.

William J Elliott1.   

Abstract

Many antihypertensive drugs have important interactions with drugs used for different purposes; when these are used concomitantly, adverse effects on blood pressure can result. Fortunately, in recent years, the drug development process has generally discouraged the approval and marketing of antihypertensive drugs with this problem, although some anomalies still exist (eg, telmisartan + digoxin). Physicians who work in emergency departments are more familiar with illicit or unregulated drugs that affect blood pressure; chief among these are cocaine and other opioids, and methylphenidate and its congeners. The most important prescription drugs that affect blood pressure are the nonsteroidal anti-inflammatory drugs (including selective inhibitors of the second isoform of cyclooxygenase) and steroids. Phenylpropanolamines, some antidepressants, and sibutramine can often be avoided, as they raise blood pressure in a significant proportion of those who take them. Conversely, the hypertensive effects of calcineurin inhibitors and erythropoietin are most commonly overcome by increasing the intensity of antihypertensive drug treatment, since these drugs are essentially unavoidable in most patients who receive them.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17028488      PMCID: PMC8109496          DOI: 10.1111/j.1524-6175.2006.05939.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  12 in total

Review 1.  Antihypertensive therapy: special focus on drug interactions.

Authors:  Renke Maas; Rainer H Böger
Journal:  Expert Opin Drug Saf       Date:  2003-11       Impact factor: 4.250

Review 2.  11beta-hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action.

Authors:  Nicole Draper; Paul M Stewart
Journal:  J Endocrinol       Date:  2005-08       Impact factor: 4.286

3.  Meta-analysis of cyclooxygenase-2 inhibitors and their effects on blood pressure.

Authors:  Tai-Juan Aw; Steven Joseph Haas; Danny Liew; Henry Krum
Journal:  Arch Intern Med       Date:  2005-02-14

4.  Cyclooxygenase-2--specific inhibitors and cardiorenal function: a randomized, controlled trial of celecoxib and rofecoxib in older hypertensive osteoarthritis patients.

Authors:  A Whelton; J G Fort; J A Puma; D Normandin; A E Bello; K M Verburg
Journal:  Am J Ther       Date:  2001 Mar-Apr       Impact factor: 2.688

Review 5.  Erythropoietin and arterial hypertension.

Authors:  F C Luft
Journal:  Clin Nephrol       Date:  2000-02       Impact factor: 0.975

Review 6.  High blood pressure. A side effect of drugs, poisons, and food.

Authors:  E Grossman; F H Messerli
Journal:  Arch Intern Med       Date:  1995-03-13

7.  Influence of Sibutramine on blood pressure: evidence from placebo-controlled trials.

Authors:  J Jordan; J Scholze; B Matiba; A Wirth; H Hauner; A M Sharma
Journal:  Int J Obes (Lond)       Date:  2005-05       Impact factor: 5.095

Review 8.  Antihypertensive drug interactions.

Authors:  Barry L Carter
Journal:  Drugs Today (Barc)       Date:  2005-01       Impact factor: 2.245

Review 9.  Herbs and alternative therapies: relevance to hypertension and cardiovascular diseases.

Authors:  Chaula K Vora; George A Mansoor
Journal:  Curr Hypertens Rep       Date:  2005-08       Impact factor: 5.369

10.  Effects of celecoxib and rofecoxib on blood pressure and edema in patients > or =65 years of age with systemic hypertension and osteoarthritis.

Authors:  Andrew Whelton; William B White; Alfonso E Bello; Joseph A Puma; John G Fort
Journal:  Am J Cardiol       Date:  2002-11-01       Impact factor: 2.778

View more
  11 in total

1.  [Arterial hypertension in old age with the focus on 80].

Authors:  Dhayana Dallmeier; Michael D Denkinger
Journal:  Z Gerontol Geriatr       Date:  2018-11-06       Impact factor: 1.281

Review 2.  Chronotherapy for Hypertension.

Authors:  N P Bowles; S S Thosar; M X Herzig; S A Shea
Journal:  Curr Hypertens Rep       Date:  2018-09-28       Impact factor: 5.369

3.  Variation in the net benefit of aggressive cardiovascular risk factor control across the US population of patients with diabetes mellitus.

Authors:  Justin W Timbie; Rodney A Hayward; Sandeep Vijan
Journal:  Arch Intern Med       Date:  2010-06-28

4.  KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors.

Authors:  Krista L Lentine; Bertram L Kasiske; Andrew S Levey; Patricia L Adams; Josefina Alberú; Mohamed A Bakr; Lorenzo Gallon; Catherine A Garvey; Sandeep Guleria; Philip Kam-Tao Li; Dorry L Segev; Sandra J Taler; Kazunari Tanabe; Linda Wright; Martin G Zeier; Michael Cheung; Amit X Garg
Journal:  Transplantation       Date:  2017-08       Impact factor: 4.939

5.  Health care fragmentation and blood pressure control among adults taking antihypertensive medication.

Authors:  Calvin L Colvin; Monika M Safford; Paul Muntner; Lisandro D Colantonio; Lisa M Kern
Journal:  Am J Manag Care       Date:  2022-03       Impact factor: 3.247

Review 6.  Common Substances That May Contribute to Resistant Hypertension, and Recommendations for Limiting Their Clinical Effects.

Authors:  Samuel J Jurca; William J Elliott
Journal:  Curr Hypertens Rep       Date:  2016-10       Impact factor: 5.369

7.  Pathway analysis of seven common diseases assessed by genome-wide association.

Authors:  Ali Torkamani; Eric J Topol; Nicholas J Schork
Journal:  Genomics       Date:  2008-09-16       Impact factor: 5.736

Review 8.  Secondary hypertension: interfering substances.

Authors:  Ehud Grossman; Franz H Messerli
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-07       Impact factor: 3.738

9.  Healthcare Fragmentation and Incident Acute Coronary Heart Disease Events: a Cohort Study.

Authors:  Lisa M Kern; Mangala Rajan; Joanna Bryan Ringel; Lisandro D Colantonio; Paul M Muntner; Lawrence P Casalino; Michael Pesko; Evgeniya Reshetnyak; Laura C Pinheiro; Monika M Safford
Journal:  J Gen Intern Med       Date:  2020-11-02       Impact factor: 6.473

10.  Influence of methylphenidate treatment assumptions on cognitive function in healthy young adults in a double-blind, placebo-controlled trial.

Authors:  Jean-Luc Mommaerts; Gerlinde Beerens; Lieve Van den Block; Eric Soetens; Sandrina Schol; Erwin Van De Vijver; Dirk Devroey
Journal:  Psychol Res Behav Manag       Date:  2013-08-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.